ResearcherZhongnan Hospital of Wuhan UniversityActive in the last 2 years
Chengming Qu
Matched on ORCID iD 0000-0002-9773-8815; OpenAlex author ID A5054677565. Sources: OpenAlex.
Their work
- Papers
- 2
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 7
2024: 1 paper · 2025: 1 paper
Papers 2
- Tumor-derived exosomal CCT6A serves as a matchmaker introducing chemokines to tumor-associated macrophages in pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/s41419-025-07720-y↗
- Precise Photodynamic Therapy by Midkine Nanobody-Engineered Nanoparticles Remodels the Microenvironment of Pancreatic Ductal Adenocarcinoma and Potentiates the… Co-author DOI 10.1021/acsnano.3c07002↗
Closest collaborators
The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Peng Xia · 2 shared papers, 2024–2025 · strength 0.39
- Paper Tumor-derived exosomal CCT6A serves as a matchmaker introducing chemokines to tumor-associated macrophages in pancreati… DOI 10.1038/s41419-025-07720-y↗
- Paper Precise Photodynamic Therapy by Midkine Nanobody-Engineered Nanoparticles Remodels the Microenvironment of Pancreatic D… DOI 10.1021/acsnano.3c07002↗
- Ming Tian · 2 shared papers, 2024–2025 · strength 0.39
- Paper Tumor-derived exosomal CCT6A serves as a matchmaker introducing chemokines to tumor-associated macrophages in pancreati… DOI 10.1038/s41419-025-07720-y↗
- Paper Precise Photodynamic Therapy by Midkine Nanobody-Engineered Nanoparticles Remodels the Microenvironment of Pancreatic D… DOI 10.1021/acsnano.3c07002↗
- Yufeng Yuan · 2 shared papers, 2024–2025 · strength 0.39
- Paper Tumor-derived exosomal CCT6A serves as a matchmaker introducing chemokines to tumor-associated macrophages in pancreati… DOI 10.1038/s41419-025-07720-y↗
- Paper Precise Photodynamic Therapy by Midkine Nanobody-Engineered Nanoparticles Remodels the Microenvironment of Pancreatic D… DOI 10.1021/acsnano.3c07002↗
- Tianyin Ma · 1 shared paper, 2025 · strength 0.21
- Jie Liu · 1 shared paper, 2025 · strength 0.21
- Tengxiang Chen · 1 shared paper, 2024 · strength 0.18
- Zhiyong Yang · 1 shared paper, 2024 · strength 0.18
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.